Literature DB >> 17884127

Purification, characterization and homology analysis of ocellatin 4, a cytolytic peptide from the skin secretion of the frog Leptodactylus ocellatus.

Anna Nascimento1, Alex Chapeaurouge, Jonas Perales, Antonio Sebben, Marcelo V Sousa, Wagner Fontes, Mariana S Castro.   

Abstract

Neobatrachia is the amphibian suborder with the largest number of species and a most important source of bioactive peptides from frog skin secretions. However, 90% of the studies on this subject have been focused on the frog families Hylidae and Ranidae, while very little is known about peptides of other families, like Leptodactylidae. Our work reports for the first time the isolation and characterization of ocellatin 4 (GLLDFVTGVGKDIFAQLIKQI-NH(2)), a cytolytic peptide from the skin secretion of the South American frog Leptodactylus ocellatus. While most cytolytic amphibian skin peptides are selective for microorganisms and harmless for mammalian cells, the HC(50) of ocellatin 4 against human erythrocytes is 14.3muM. The interaction between ocellatin 4 and zwitterionic phospholipids in mammalian plasma membranes may be favored by its neutral charge at pH 7.0. Ocellatin 4 also shows some antibacterial activity (MICs(E. coli)(and)(S. aureus)=64muM) and its sequence shares similarities with the only six leptodactylid peptides previously known and with four peptides from Australian hylid frogs of the genus Litoria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884127     DOI: 10.1016/j.toxicon.2007.07.014

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

1.  Unravelling the molecular effect of ocellatin-1, F1, K1 and S1, the frog-skin antimicrobial peptides to enhance its therapeutics-quantum and molecular mechanical approaches.

Authors:  P Chandra Sekar; D Meshach Paul; E Srinivasan; R Rajasekaran
Journal:  J Mol Model       Date:  2021-01-03       Impact factor: 1.810

2.  The crude skin secretion of the pepper frog Leptodactylus labyrinthicus is rich in metallo and serine peptidases.

Authors:  Michelle da Silva Libério; Izabela M D Bastos; Osmindo R Pires Júnior; Wagner Fontes; Jaime M Santana; Mariana S Castro
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

3.  Evaluation of the effects of ischemic preconditioning on the hematological parameters of rats subjected to intestinal ischemia and reperfusion.

Authors:  Muhammad Tahir; Samina Arshid; Ana Maria C Heimbecker; Mariana S Castro; Edna Frasson de Souza Montero; Belchor Fontes; Wagner Fontes
Journal:  Clinics (Sao Paulo)       Date:  2015-01       Impact factor: 2.365

4.  Leptodactylus latrans Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides.

Authors:  Alvaro Siano; Maria Veronica Humpola; Eliandre de Oliveira; Fernando Albericio; Arturo C Simonetta; Rafael Lajmanovich; Georgina G Tonarelli
Journal:  Molecules       Date:  2018-11-11       Impact factor: 4.411

5.  Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.

Authors:  Rosangela Naomi Inui Kishi; Dagmar Stach-Machado; Junya de Lacorte Singulani; Claudia Tavares Dos Santos; Ana Marisa Fusco-Almeida; Eduardo Maffud Cilli; Juliana Freitas-Astúa; Simone Cristina Picchi; Marcos Antonio Machado
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

6.  Phosphoproteomic Analysis of Rat Neutrophils Shows the Effect of Intestinal Ischemia/Reperfusion and Preconditioning on Kinases and Phosphatases.

Authors:  Muhammad Tahir; Samina Arshid; Belchor Fontes; Mariana S Castro; Simone Sidoli; Veit Schwämmle; Isabelle S Luz; Peter Roepstorff; Wagner Fontes
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 7.  Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks.

Authors:  Carlos F M Morris; Muhammad Tahir; Samina Arshid; Mariana S Castro; Wagner Fontes
Journal:  J Immunol Res       Date:  2015-12-06       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.